B. Braun Medical, Inc.
824 Twelfth Avenue
Bethlehem, PA 18018
News | Drug-Eluting Balloons | August 02, 2019
B. Braun Interventional Systems Inc. (BIS) announced the U.S. Food and Drug Administration (FDA) has granted...
Feature | Drug-Eluting Balloons | November 02, 2017
November 2, 2017 — The treatment of in-stent restenosis (ISR) remains challenging in clinical practice.
News | Cath Lab | August 17, 2015
The global interventional cardiology devices market is expected to reach $25.16 billion by 2020, according to a new...
Feature | September 26, 2014
A new clinical trial comparing the use of everolimus-eluting stents (EES) and drug-eluting balloons (DEB) in treating...
News | February 22, 2010
February 22, 2010 – As part of a comarketing and trademark license agreement between MEDRAD Inc. and B. Braun Melsungen...
Feature | June 23, 2009 | Dave Fornell
The focus on balloon angioplasty largely slipped from the interventional limelight a decade ago after the introduction...
News | October 24, 2007
October 24, 2007 — Drug-eluting balloons could offer a viable alternative to drug-eluting stents (DES) in the treatment...